Retro Biosciences vs MasterControl
Side-by-side comparison of AI visibility scores, market position, and capabilities
Largest-funded pure-play longevity startup raising $1B Series A at $5B valuation; Sam Altman-backed; pursuing cellular reprogramming, autophagy, and plasma factor therapeutics in parallel; first human trial targeting Australia launch.
About
Retro Biosciences is the largest-funded pure-play longevity company in history, raising $1 billion in Series A financing at a $5 billion valuation with Sam Altman (OpenAI CEO) as a primary backer. The company is pursuing cellular reprogramming, autophagy enhancement, and plasma factor therapeutics in parallel — a multi-pronged approach to extending healthy human lifespan by targeting the cellular hallmarks of aging simultaneously.
MasterControl is the leading QMS and MES platform for regulated life sciences industries, serving 1,100+ companies with $200M revenue in 2025; valued at $1.3B after $150M from Sixth Street, acquired Qualer in Mar 2025.
About
MasterControl is a leading provider of quality management system (QMS) and manufacturing execution system (MES) software for regulated industries, with a primary focus on pharmaceuticals, medical devices, biotechnology, and food and beverage. The company's AI-powered platform digitizes and automates compliance-critical workflows including document control, training management, audit management, change control, corrective and preventive action (CAPA), risk management, and electronic batch records — replacing paper-based processes that are error-prone, audit-vulnerable, and incompatible with modern manufacturing velocity.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.